Express News | Celldex Initiates Phase 2 Study of Barzolvolimab in Atopic Dermatitis

BreakingsDec 19 21:01

Celldex Therapeutics Doses First Patient in Study of Potential Inflammatory Disease Treatment

MT NewswiresNov 20 21:56

Express News | Celldex Therapeutics Inc - Subcutaneous Formulation to Be Added to Study in 2025

BreakingsNov 20 21:01

Express News | Celldex Announces First Patient Dosed in Phase 1 Healthy Volunteer Study of Cdx-622, a Bispecific Antibody, for the Treatment of Inflammatory Diseases

BreakingsNov 20 21:01

Beyond The Numbers: 11 Analysts Discuss Celldex Therapeutics Stock

BenzingaNov 20 20:00

Founder of Celldex Therapeutics Anthony Marucci Buys 40% More Shares

Simply Wall StNov 15 19:17